439 results on '"Nguyen, P.L."'
Search Results
2. Indications for Adjuvant Radiation after Radical Prostatectomy as Predicted by Artificial Intelligence-Derived Dominant Intraprostatic Lesion Volume
3. Genomic Characterization of Locally Recurrent Prostate Cancer after Radiation Therapy
4. Trends in Utilization and Medicare Spending on Shorter vs. Longer Radiotherapy Courses for Breast and Prostate Cancer
5. FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (Apa) Post-Radical Prostatectomy (RP)
6. Health Equity Achievement in Radiation Therapy (HEART) Score: A Social Prognosis
7. Long-Term Follow-Up Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Non-Inferiority Study Comparing Two Fractionation Schedules in Patients with Favorable-Risk Prostate Cancer
8. Determinants of Widespread Metastases and of Metastatic Tropism in Patients with Prostate Cancer: A Genomic Analysis of Primary and Metastatic Tumors
9. Association between Artificial Intelligence-Derived Tumor Volume and Oncologic Outcomes for Localized Prostate Cancer Treated with Radiation Therapy
10. Androgen deprivation therapy and risk of rheumatoid arthritis in patients with localized prostate cancer
11. A Case of Initially Misdiagnosed Antisynthetase Syndrome With Characteristic Nonspecific Interstitial Pneumonia/Organizing Pneumonia Overlap
12. Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States
13. Characterizing the Performance of a Deep-Learning Segmentation Algorithm for Outlining Dominant Intraprostatic Lesions on Prostate Multi-Parametric MRI
14. Intensity-modulated radiation therapy leads to survival benefit only in patients with high-risk prostate cancer: a population-based study
15. Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer
16. Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes
17. Association Between Treatment Modality and Probability of Second Malignancy in Localized Prostate Cancer Patients
18. Validation of a 22-gene Genomic Classifier in the NRG Oncology/RTOG 9202, 9413 and 9902 Phase III Randomized Trials: A Biopsy-Based Individual Patient Meta-Analysis in High-Risk Prostate Cancer
19. Trends in Receipt of Shorter Regimens of Radiation Therapy and Treatment Noncompletion Disparities Among Breast and Prostate Cancer Patients in the United States
20. Radiation Dose to the Intraprostatic Urethra Correlates Strongly With Urinary Toxicity Following Prostate SBRT: A Combined Analysis of 23 Prospective Clinical Trials
21. Prognostic and Predictive Performance of Routine Clinicopathologic Variables in 10,535 Men Enrolled on Randomized Phase III Trials in Localized Prostate Cancer
22. Mixed Methods Evaluation of a Targeted One-Week Virtual Radiation Oncology Intensive Shadowing Experience for Medical Students Underrepresented in Medicine: Mentor's Perspective
23. Clinical and Dosimetric Outcomes of MR Guided Prostate SBRT With Daily Online Plan Adaptation
24. Development & Impact of a Virtual PSA Monitoring Clinic for Follow-up of Prostate Cancer Patients: An Efficient Model With Unique Benefits Relevant to COVID-19
25. The Influence of the Pretreatment Host Immune State on Response to Radiation Therapy in High Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521 (Updated)
26. Mental Distress and Mental Health Services Receipt in Foreign Born Survivors of Cancer: A National Health Interview Survey Analysis
27. Clinical-Genomic Sub-classification of High-Risk Prostate Cancer: Implications for Tailoring Therapy and Clinical Trial Design
28. OC-1027: Comparing GU toxicity of LDR I-125 prostate brachytherapy by robotic and manual loading techniques
29. Meta-Analysis of Salvage Therapy Following Definitive Radiotherapy for Prostate Cancer
30. Characteristics of Radiation-Associated Bladder Cancer Compared To Primary Bladder Cancer
31. Association Between Percentage of Positive Biopsy Cores and Risk of Pelvic Lymph Node Involvement in Prostate Cancer
32. Exercise Patterns among Survivors of Cancer in the United States, 2011—2018
33. Quantifying Treatment Selection Bias Effects on Survival in National Database Studies: Findings from Low-Risk Prostate Cancer Patients
34. The Association Between Physical Functioning and Healthcare Utilization Among Cancer Survivors
35. Association Between Travel Distance and Use of Post-Operative Radiation Therapy Among Men With Prostate Cancer: Does Geography Influence Treatment Decisions?
36. The Association Between Mental Distress and Access to Mental Health Services Among Cancer Survivors
37. Association Between T-Stage and Cancer-Specific Mortality among Men with High-Risk Prostate Adenocarcinoma
38. Marginless Radiotherapy (MRT): Leveraging The Abscopal Effect Toward The Treatment Of Metastatic Castration Resistant Prostate Cancer
39. Association Between Black Race And Improved Survival Following Sipuleucel-T Immunotherapy In Metastatic Castrate-Resistant Prostate Cancer: Implications For Immune Biology And Integration Of Radiation Therapy With Immunotherapy
40. The Impact of Persistently Elevated PSA after Prostatectomy in Men with Recurrent Prostate Cancer in NRG Oncology/RTOG 9601
41. NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Post-Operative Prostate Cancer
42. Comorbidity-based Racial Disparities in Prostate Cancer: The Case for Effect Modification
43. Associations of Stromal Infiltration with Prognosis and Response to Postoperative Radiotherapy in Prostate Cancer
44. Racial Disparities in Culturally Competent Health Care among Cancer Survivors in the United States
45. Expanding Global Access to Breast and Prostate Radiotherapy through Evidence-based Hypofractionation Techniques
46. Clinical Outcomes among Patients with Radiorecurrent Gleason Grade Group 5 Prostate Cancer: Impact of Initial Treatment Strategy
47. Impact of Prostate-Directed Radiation Therapy on Overall Survival for Patients with M1a Prostate Cancer
48. Transcriptomic Heterogeneity in Pathological Grade Group 5 Prostate Cancer: Implications for Biomarker Discovery
49. Conservative Management for Low-Risk Prostate Cancer in Black Patients: A Population-Based Analysis
50. The Effect of Race and Decision Aids on Provider Recommendation for Prostate Cancer Treatment Planning: A Randomized Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.